<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04907045</url>
  </required_header>
  <id_info>
    <org_study_id>218046</org_study_id>
    <secondary_id>R01DA047954</secondary_id>
    <nct_id>NCT04907045</nct_id>
  </id_info>
  <brief_title>An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care</brief_title>
  <acronym>DIGITS Pilot</acronym>
  <official_title>Digital Therapeutics for Opioids and Other Substance Use Disorders in Primary Care Pilot (DIGITS Trial Pilot)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments&#xD;
      for opioids and other substance use disorders in primary care. In this pilot study, the&#xD;
      FDA-authorized reSET and reSET-O digital therapeutics will be implemented in 2 primary care&#xD;
      clinics as part of quality improvement. The study will test and refine the two experimental&#xD;
      implementation strategy interventions, health coaching (patient-facing) and practice coaching&#xD;
      (clinician-facing). This study will also pilot economic data collection tools and collect&#xD;
      qualitative data for a formative evaluation. The analytic goals are to inform the statistical&#xD;
      design and data collection processes for the subsequent cluster-randomized DIGITS Trial.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2021</start_date>
  <completion_date type="Anticipated">December 2, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Non-randomized parallel groups pilot study to evaluate intervention delivery, data collection, and analysis procedures. Two primary care clinics will implement the reSET and reSET-O digital therapeutics for substance use disorders. There will be one clinic per arm in this pilot study. Implementation strategies will be varied across arms.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reach of the digital therapeutic to patients in the primary care clinic</measure>
    <time_frame>3 months</time_frame>
    <description>The proportion of patients who initiate the digital therapeutic, defined by instances in which patients open the app, enter the prescription code, and use a treatment module</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fidelity of patients use of the digital therapeutic to clinical recommendations</measure>
    <time_frame>6 months</time_frame>
    <description>Mean number of weeks in which patients use 4 app modules/week and have visited a clinician in the past month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>6 months</time_frame>
    <description>Mean number of months in which patients make monthly visits for substance use disorder</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Reach-2</measure>
    <time_frame>3 months</time_frame>
    <description>The proportion of patients prescribed reSET or reSET-O</description>
  </other_outcome>
  <other_outcome>
    <measure>Reach-3</measure>
    <time_frame>3 months</time_frame>
    <description>The proportion of patients who download and unlock reSET or reSET-O</description>
  </other_outcome>
  <other_outcome>
    <measure>Fidelity-2</measure>
    <time_frame>6 months</time_frame>
    <description>Mean number of weeks in which patients use at least 1 module/week</description>
  </other_outcome>
  <other_outcome>
    <measure>Fidelity-3</measure>
    <time_frame>6 months</time_frame>
    <description>Mean number of weeks in which patients use at least 4 modules/week</description>
  </other_outcome>
  <other_outcome>
    <measure>Adoption</measure>
    <time_frame>3 months</time_frame>
    <description>The proportion of other healthcare providers initiating a patient on reSET or reSET-O, overall and by provider type</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Drug Use Disorders</condition>
  <condition>Illicit Drug Use</condition>
  <condition>Alcohol-Related Disorders</condition>
  <arm_group>
    <arm_group_label>Standard Implementation Plus Health Coaching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The clinic in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Implementation Plus Health Coaching and Practice Facilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The clinic in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O. Additionally, a practice facilitator will provide the clinic with support for implementation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health Coaching</intervention_name>
    <description>The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.</description>
    <arm_group_label>Standard Implementation Plus Health Coaching</arm_group_label>
    <arm_group_label>Standard Implementation Plus Health Coaching and Practice Facilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Practice Facilitation</intervention_name>
    <description>In the context of a supportive relationship, a trained facilitator delivers the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.</description>
    <arm_group_label>Standard Implementation Plus Health Coaching and Practice Facilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Implementation</intervention_name>
    <description>Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.</description>
    <arm_group_label>Standard Implementation Plus Health Coaching</arm_group_label>
    <arm_group_label>Standard Implementation Plus Health Coaching and Practice Facilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Had a primary care visit in a participating clinic during the pilot&#xD;
&#xD;
          -  Screened positive for substance use&#xD;
&#xD;
          -  Adult aged 18 years or older at time of visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph E Glass, PhD, MSW</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joseph E Glass, PhD, MSW</last_name>
    <phone>206-287-4266</phone>
    <email>joseph.e.glass@kp.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tara C Beatty, MA</last_name>
    <phone>206-442-4012</phone>
    <email>tara.c.beatty@kp.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kaiser Permanente Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tara Beatty, MA</last_name>
      <phone>206-442-4012</phone>
      <email>Tara.C.Beatty@kp.org</email>
    </contact>
    <investigator>
      <last_name>Joseph E Glass, PhD MSW</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Implementation Science</keyword>
  <keyword>Mobile Applications</keyword>
  <keyword>Drug Use Disorders</keyword>
  <keyword>Quality Improvement</keyword>
  <keyword>Primary Health Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Alcohol-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

